SE8305485L - Galeniska kompositioner innefattande kalcitonin och deras anvendning - Google Patents

Galeniska kompositioner innefattande kalcitonin och deras anvendning

Info

Publication number
SE8305485L
SE8305485L SE8305485A SE8305485A SE8305485L SE 8305485 L SE8305485 L SE 8305485L SE 8305485 A SE8305485 A SE 8305485A SE 8305485 A SE8305485 A SE 8305485A SE 8305485 L SE8305485 L SE 8305485L
Authority
SE
Sweden
Prior art keywords
compositions including
galenic compositions
nasal
calcitonin
including calcitonin
Prior art date
Application number
SE8305485A
Other languages
English (en)
Other versions
SE8305485D0 (sv
SE455671B (sv
Inventor
Moise Azria
Thomas Cavanak
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27449393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8305485(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB838320865A external-priority patent/GB8320865D0/en
Priority claimed from GB838322528A external-priority patent/GB8322528D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8305485D0 publication Critical patent/SE8305485D0/sv
Publication of SE8305485L publication Critical patent/SE8305485L/sv
Publication of SE455671B publication Critical patent/SE455671B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SE8305485A 1982-10-05 1983-10-05 Flytande farmaceutisk komposition for nasal administration innefattande en kalcitonin och bensalkoniumklorid samt behallare for denna komposition SE455671B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8228390 1982-10-05
GB8236928 1982-12-30
GB838320865A GB8320865D0 (en) 1983-08-03 1983-08-03 Organic compounds
GB838322528A GB8322528D0 (en) 1983-08-22 1983-08-22 Organic compounds

Publications (3)

Publication Number Publication Date
SE8305485D0 SE8305485D0 (sv) 1983-10-05
SE8305485L true SE8305485L (sv) 1984-04-06
SE455671B SE455671B (sv) 1988-08-01

Family

ID=27449393

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8305485A SE455671B (sv) 1982-10-05 1983-10-05 Flytande farmaceutisk komposition for nasal administration innefattande en kalcitonin och bensalkoniumklorid samt behallare for denna komposition

Country Status (21)

Country Link
US (2) US5759565A (sv)
JP (1) JPH07103043B2 (sv)
AT (1) AT394947B (sv)
AU (2) AU572800B2 (sv)
CA (1) CA1220138A (sv)
CH (1) CH657779A5 (sv)
DE (1) DE3335086A1 (sv)
DK (1) DK161800C (sv)
FR (1) FR2533826B1 (sv)
HK (1) HK27389A (sv)
HU (1) HU192246B (sv)
IL (1) IL69892A (sv)
IT (1) IT1172324B (sv)
KE (1) KE3848A (sv)
MY (1) MY8700271A (sv)
NL (1) NL192563C (sv)
NZ (1) NZ205846A (sv)
PH (1) PH22725A (sv)
PT (1) PT77443B (sv)
SE (1) SE455671B (sv)
SG (1) SG76388G (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
US5571788A (en) * 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
EP0726075A1 (en) * 1995-02-08 1996-08-14 Therapicon Srl Pharmaceutical non-inorganic saline solutions for endonasal administration
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
WO2001056594A1 (en) 2000-02-04 2001-08-09 Unigene Laboratories, Inc. Nasal calcitonin formulations
US6531112B2 (en) * 2000-05-15 2003-03-11 Delrx Pharmaceutical Corporation Formulations for administering calcitonin and processes for preparing the same
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
US7166575B2 (en) * 2002-12-17 2007-01-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
US7229966B2 (en) * 2002-12-17 2007-06-12 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
US7186692B2 (en) * 2002-12-17 2007-03-06 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
AU2003299722A1 (en) * 2002-12-17 2004-07-14 Mdrna, Inc. Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
AU2004281532B2 (en) * 2003-10-15 2010-03-18 Pari Pharma Gmbh Liquid preparation containing tobramycin
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US20100256060A1 (en) * 2009-04-02 2010-10-07 Unigene Laboratories Inc. Peptide pharmaceuticals for nasal delivery
EP3272769B1 (en) 2012-01-26 2020-06-17 Christopher J. Soares Peptide antagonists of the calcitonin cgrp family of peptide hormones and their use
WO2018045083A1 (en) 2016-09-02 2018-03-08 Soares Christopher J Use of cgrp receptor antagonists in neuroprotection and neurological disorders
US10723716B2 (en) 2016-12-21 2020-07-28 New York University Alpha-helix mimetics as modulators of Abeta self-assembly
US11124479B2 (en) 2017-07-14 2021-09-21 New York University Oligopyrroles as antagonists of islet amyloid polypeptide oligomerization
US10500197B2 (en) 2017-07-18 2019-12-10 New York University Use of oligopyridylamides to inhibit mutant p53 amyloid formation and restore its tumor suppressor function

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769405A (en) * 1970-04-17 1973-10-30 Armour Pharma Methods for obtaining diuresis
CH539556A (de) * 1971-03-16 1973-07-31 Ciba Geigy Ag Applikator zur dosierten Ausgabe einer Flüssigkeit
GB1354526A (en) * 1971-04-19 1974-06-05 Armour Pharma Preparation for obtaining diuresis in animals
GB1527605A (en) * 1975-08-20 1978-10-04 Takeda Chemical Industries Ltd Insulin preparation for intranasal administration
GB2008403B (en) * 1977-11-04 1982-07-28 Christie R B Parsons J A Pharmaceutical compositions
US4241051A (en) * 1977-11-04 1980-12-23 Christie Robert B Calcitonin
DE2903957A1 (de) * 1979-02-02 1980-08-07 Boehringer Sohn Ingelheim Mittel zur behandlung der nasalen hypersekretion
JPS5625197A (en) * 1979-07-19 1981-03-10 Microbial Chem Res Found Cleomycin and its preparation
JPS56100714A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
JPS56122309A (en) * 1980-03-03 1981-09-25 Teijin Ltd Calcitonin pharmaceutical for rectal administration
EP0053754B1 (de) * 1980-12-06 1986-04-23 Reichert, Dietrich, Dr. med. Mittel zur Bekämpfung des Schnarchens und Verfahren zu dessen Anwendung
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina

Also Published As

Publication number Publication date
IL69892A (en) 1987-12-31
PT77443B (en) 1986-04-11
NL8303386A (nl) 1984-05-01
FR2533826B1 (fr) 1987-06-12
CH657779A5 (de) 1986-09-30
AU2103588A (en) 1988-12-22
PT77443A (en) 1983-11-01
IT8349105A0 (it) 1983-10-05
FR2533826A1 (fr) 1984-04-06
HUT34121A (en) 1985-02-28
MY8700271A (en) 1987-12-31
DK161800B (da) 1991-08-19
DK161800C (da) 1992-01-27
KE3848A (en) 1989-03-31
IL69892A0 (en) 1984-01-31
SG76388G (en) 1989-03-23
HU192246B (en) 1987-05-28
SE8305485D0 (sv) 1983-10-05
CA1220138A (en) 1987-04-07
DE3335086A1 (de) 1984-05-03
DK458183D0 (da) 1983-10-04
SE455671B (sv) 1988-08-01
PH22725A (en) 1988-11-28
HK27389A (en) 1989-04-07
JPH07103043B2 (ja) 1995-11-08
AT394947B (de) 1992-07-27
DE3335086C2 (sv) 1990-09-20
DK458183A (da) 1984-04-06
JPH02262526A (ja) 1990-10-25
IT1172324B (it) 1987-06-18
NL192563B (nl) 1997-06-02
US5759565A (en) 1998-06-02
NL192563C (nl) 1997-10-03
AU572800B2 (en) 1988-05-19
NZ205846A (en) 1987-09-30
ATA349483A (de) 1992-01-15
AU1984983A (en) 1984-04-12
US5733569A (en) 1998-03-31

Similar Documents

Publication Publication Date Title
SE8305485L (sv) Galeniska kompositioner innefattande kalcitonin och deras anvendning
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
MY101791A (en) New benzimidazole derivatives
FI971776A (sv) Föreningar och sammasättningar för administrering av aktiva ämnen
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
SE8804629D0 (sv) New therapeutically active compounds
DE69318503D1 (de) Ein definiertes lipidsystem enthaltende pharmazeutische zusammensetzung
MY102422A (en) Intranasally applicable powdery pharmaceutical composition.
DE69328192D1 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
SE8700499D0 (sv) Novel pharmacologically active compounds
FI941771A0 (sv) Effektiverat hudpenetreringssystem för förbättrad lokal administration av läkemedel
DE69940674D1 (de) Orale verabreichung von adenosin analogen
ATE225647T1 (de) Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
FI892454A (fi) Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma.
DE60019334D1 (de) Antivirale arznei
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
ES2080314T3 (es) Composiciones farmaceuticas.
MY102411A (en) Nasal solutions
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
BE899277A (fr) Agents antimycotiques a haute liberation de substance active sous forme d'une solution et d'une pulverisation.
NL192325B (nl) Waterig, nasaal farmaceutisch preparaat dat dehydroergotamine bevat en sproeitoedieningsinrichting.
SE8704049D0 (sv) Novel pharmacological compounds
IT9019126A0 (it) Composizioni galeniche per la somministrazione nasale e rettale di calcitonina

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8305485-8

Format of ref document f/p: F

NUG Patent has lapsed